NYSE:ANRO) Alto Neuroscience Inc Is Being Investigated For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm ...

Alto Neuroscience, Inc. (ANRO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...

On track to report data from Phase 1 clinical trial evaluating VG-3927 for the treatment of Alzheimer’s disease in 1Q 2025 – ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients ...

Two new neuroscience studies offer fascinating answers ... The opinions expressed here by Inc.com columnists are their own, not those of Inc.com.

Geode Capital Management LLC grew its holdings in shares of Alto Neuroscience, Inc. (NYSE:ANRO – Free Report) by 148.7% in ...

Firefly Neuroscience, Inc. has announced the closing of a financing deal valued at up to $12.4 million, which includes $2.4 million in senior secured convertible notes and an equity line of credit ...

Vigil Neuroscience, Inc. (NASDAQ:VIGL – Get Free Report) saw a significant decline in short interest in December. As of December 15th, there was short interest totalling 681,400 shares, a decline of ...

Aspen Neuroscience, Inc. has advanced its plans for automating production of ANPD001, including a capacity expansion for autologous manufacturing at its San Diego -based GMP facility.

NYSE:ANRO) Alto Neuroscience Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm ...